Endurant Capital Management LP Standard Biotools Inc. Transaction History

Endurant Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.85 - $5.29 $429,738 - $1.23 Million	-232,291 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.24 - $4.35 $994,904 - $3.49 Million	-802,342 Reduced 77.55%	232,291 $590,000
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $1.47 Million - $3.27 Million	638,932 Added 161.47%	1,034,633 $3.6 Million
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $1.83 Million - $4.81 Million	395,701 New	395,701 $1.83 Million
Q1 2019 May 15, 2019	SELL	$8.47 - $14.36 $2 Million - $3.4 Million	-236,648 Closed	0 $0

Q4 2018 Feb 14, 2019	SELL	$7.18 - $8.83 $2.34 Million - $2.88 Million	-325,936 Reduced 57.94%	236,648 $2.04 Million
Q3 2018 Nov 14, 2018	BUY	$5.92 - $8.35 $2.65 Million - $3.74 Million	448,474 Added 393.02%	562,584 $4.21 Million
Q2 2018 Aug 14, 2018	BUY	$4.86 - $6.24 $554,574 - $712,046	114,110 New	114,110 $680,000

146

265M

356K

400

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $146M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.